Dr Zool Hilmi bin Awang serves as the Head of the Nuclear Medicine Department at Thomson Hospital, with a distinguished background that includes a Master of Nuclear Medicine from Universiti Sains Malaysia (USM) and a Fellowship in Theranostic Nuclear Medicine from Germany. Responsible for developing the Nuclear Medicine Department at Thomson Hospital from scratch, Dr Zool Hilmi has established a comprehensive range of nuclear medicine services that have positioned the department at the forefront of the field. The therapeutic services introduced include:
• Iodine-131 Therapy for benign thyroid disease and thyroid cancer
• Lutetium-177 PSMA Therapy for prostate cancer
• Lutetium-177 DOTA Therapy for neuroendocrine tumors
• Yttrium-90 Selective Internal Radiation Therapy (SIRT) for liver cancer
In addition to therapeutic interventions, the department offers an array of diagnostic services, such as:
• Tc-99m Bone Scans
• Thyroid and Renal Scans
• Post-Therapy Scans for Iodine-131 and Lu-177 PSMA/DOTA therapies
• Dosimetry and other advanced imaging procedures
The department, under Dr Zool Hilmi’s leadership, continues to provide cutting-edge care, advancing the field of nuclear medicine and ensuring patients receive the highest standards of diagnostic and therapeutic services.